Educational only. Not medical advice. Invite-only research preview.No PHI. Do not share patient names or identifying information (HIPAA).
MytoIntelligence
All targets

Molecular target

β1-Adrenergic Receptor

Predominantly cardiac adrenergic receptor; antagonism reduces heart rate, contractility, and renin release. Targeted by cardioselective beta-blockers (metoprolol, atenolol, bisoprolol).

20 drugs act here1 plant reach it via their compounds

Educational use only. This page summarizes published research and traditional-use records for educational purposes. It does not diagnose, treat, cure, or prevent any disease. Do not start, stop, or change medications based on this information. Discuss any decisions about therapies — pharmaceutical or botanical — with a qualified clinician who knows your medical history.

No PHI / HIPAA notice: Do not share Protected Health Information (PHI) of any patient on this site — including names, dates of birth, addresses, MRNs, or any identifying information. Use abstract case framing only. Sharing PHI with non-covered entities risks HIPAA violation regardless of platform capability.

Pharmaceutical agents

Drugs that act on β1-Adrenergic Receptor

These medications have β1-Adrenergic Receptor among their molecular targets. Sharing a target is a mechanistic relationship — it does not make any plant below an alternative to, or substitute for, these drugs.

Botanical connections

Plants whose compounds act on β1-Adrenergic Receptor

Each plant below contains a named compound documented to act on β1-Adrenergic Receptor. The compound and the reason for the connection are shown on every edge — a shared mechanism, not a therapeutic equivalence.

  • Ephedrinephenethylamine alkaloid

    Indirect-acting sympathomimetic (releases norepinephrine from sympathetic nerve terminals) plus direct α1, β1, β2 adrenergic agonism. The combination produces vasoconstriction, increased cardiac output, and bronchodilation — therapeutic for bronchospasm and decongestion but at significant cardiovascular cost.

  • Pseudoephedrinephenethylamine stereoisomer

    Stereoisomer of ephedrine with greater nasal-decongestant selectivity — the basis for FDA-permitted single-ingredient pseudoephedrine OTC products (Sudafed). Lower cardiovascular impact than ephedrine but still meaningful at high dose.

A shared molecular target shows how a botanical and a drug relate mechanistically. It is not evidence that one can replace the other. Educational summary only — discuss any medication decision with your clinician.